{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:35:29Z","timestamp":1785537329384,"version":"3.56.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fragile X syndrome (FXS), the leading genetic cause of intellectual disability, arises from\n                    <jats:italic>FMR1<\/jats:italic>\n                    gene silencing and the subsequent loss of the RNA-binding protein FMRP. N6-methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) is a prevalent mRNA modification essential for post-transcriptional regulation. FMRP binds and regulates the stability of m\n                    <jats:sup>6<\/jats:sup>\n                    A-containing transcripts. However, how FMRP deficiency impacts transcriptome-wide m\n                    <jats:sup>6<\/jats:sup>\n                    A modifications in FXS remains unknown. To address this, we generated cortical neurons from induced pluripotent stem cells (iPSCs) derived from healthy individuals and FXS patients. Electrophysiology recordings revealed synaptic and neuronal network defects in FXS iPSC-derived neurons. Transcriptome-wide analysis revealed striking m\n                    <jats:sup>6<\/jats:sup>\n                    A hypermethylation predominantly affecting synapse-associated transcripts. Mechanistically, we demonstrated that FMRP deficiency drives the aberrant translational upregulation of core m\n                    <jats:sup>6<\/jats:sup>\n                    A writers, a causal relationship definitively validated using CGG-corrected isogenic control lines. Targeted genetic knockdown of the m\n                    <jats:sup>6<\/jats:sup>\n                    A writer METTL3 successfully rescued synaptic phenotypes in FXS neurons, whereas its overexpression in control neurons phenocopied these synaptic defects, confirming the causal role of m\n                    <jats:sup>6<\/jats:sup>\n                    A dysregulation in FXS pathology. Notably, pharmacological intervention with the METTL3 inhibitor STM-2457 normalized methylation on synapse-associated transcripts and restored synaptic transmission in FXS neurons. Together, our findings uncover an FMRP-dependent epitranscriptomic mechanism contributing to FXS pathogenesis and suggest a promising avenue for m\n                    <jats:sup>6<\/jats:sup>\n                    A-targeted therapies.\n                  <\/jats:p>","DOI":"10.1038\/s41380-026-03800-3","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:28:49Z","timestamp":1785522529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The m6A-mediated epi-transcriptomic dysregulation drives synaptic dysfunction in fragile X syndrome"],"prefix":"10.1038","author":[{"given":"Lu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avijite Kumer","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1340-0545","authenticated-orcid":false,"given":"Yanchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyo Han","family":"Thwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crace","family":"Westerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maag","family":"Chelsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monzon","family":"Stephanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-7693","authenticated-orcid":false,"given":"Yaping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-9229","authenticated-orcid":false,"given":"Ling-Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9793-9836","authenticated-orcid":false,"given":"Jason","family":"Tchieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-2527","authenticated-orcid":false,"given":"Christina","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Pedapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-2469","authenticated-orcid":false,"given":"Nathan","family":"Salomonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-0797","authenticated-orcid":false,"given":"Ziyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"3800_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","volume":"27","author":"MF Bear","year":"2004","unstructured":"Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004;27:370\u20137.","journal-title":"Trends Neurosci"},{"key":"3800_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1113\/jphysiol.2008.150722","volume":"586","author":"G Dolen","year":"2008","unstructured":"Dolen G, Bear MF. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J Physiol. 2008;586:1503\u20138.","journal-title":"J Physiol"},{"key":"3800_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrd.2017.221","volume":"17","author":"EM Berry-Kravis","year":"2018","unstructured":"Berry-Kravis EM, Lindemann L, Jonch AE, Apostol G, Bear MF, Carpenter RL, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018;17:280\u201399.","journal-title":"Nat Rev Drug Discov"},{"key":"3800_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11689-017-9186-9","volume":"9","author":"CA Erickson","year":"2017","unstructured":"Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, et al. Fragile X targeted pharmacotherapy: lessons learned and future directions. J Neurodev Disord. 2017;9:7.","journal-title":"J Neurodev Disord"},{"key":"3800_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","volume":"172","author":"XS Liu","year":"2018","unstructured":"Liu XS, Wu H, Krzisch M, Wu X, Graef J, Muffat J, et al. Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene. Cell. 2018;172:979\u201392 e976.","journal-title":"Cell"},{"key":"3800_CR6","doi-asserted-by":"publisher","first-page":"eaan8784","DOI":"10.1126\/scisignal.aan8784","volume":"11","author":"VS Achuta","year":"2018","unstructured":"Achuta VS, Moykkynen T, Peteri UK, Turconi G, Rivera C, Keinanen K, et al. Functional changes of AMPA responses in human induced pluripotent stem cell-derived neural progenitors in fragile X syndrome. Sci Signal. 2018;11:eaan8784.","journal-title":"Sci Signal"},{"key":"3800_CR7","doi-asserted-by":"publisher","first-page":"eaar4338","DOI":"10.1126\/scitranslmed.aar4338","volume":"10","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Marro SG, Zhang Y, Arendt KL, Patzke C, Zhou B, et al. The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling. Sci Transl Med. 2018;10:eaar4338.","journal-title":"Sci Transl Med"},{"key":"3800_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108991","volume":"35","author":"N Raj","year":"2021","unstructured":"Raj N, McEachin ZT, Harousseau W, Zhou Y, Zhang F, Merritt-Garza ME, et al. Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis. Cell Rep. 2021;35:108991.","journal-title":"Cell Rep"},{"key":"3800_CR9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41593-021-00913-6","volume":"24","author":"Y Kang","year":"2021","unstructured":"Kang Y, Zhou Y, Li Y, Han Y, Xu J, Niu W, et al. A human forebrain organoid model of fragile X syndrome exhibits altered neurogenesis and highlights new treatment strategies. Nat Neurosci. 2021;24:1377\u201391.","journal-title":"Nat Neurosci"},{"key":"3800_CR10","doi-asserted-by":"publisher","first-page":"112344","DOI":"10.1016\/j.celrep.2023.112344","volume":"42","author":"SD Sharma","year":"2023","unstructured":"Sharma SD, Reddy BK, Pal R, Ritakari TE, Cooper JD, Selvaraj BT, et al. Astrocytes mediate cell non-autonomous correction of aberrant firing in human FXS neurons. Cell Rep. 2023;42:112344.","journal-title":"Cell Rep"},{"key":"3800_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","volume":"22","author":"JD Richter","year":"2021","unstructured":"Richter JD, Zhao X. The molecular biology of FMRP: new insights into fragile X syndrome. Nat Rev Neurosci. 2021;22:209\u201322.","journal-title":"Nat Rev Neurosci"},{"key":"3800_CR12","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/nn.3379","volume":"16","author":"JC Darnell","year":"2013","unstructured":"Darnell JC, Klann E. The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci. 2013;16:1530\u20136.","journal-title":"Nat Neurosci"},{"key":"3800_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","volume":"146","author":"JC Darnell","year":"2011","unstructured":"Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146:247\u201361.","journal-title":"Cell"},{"key":"3800_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0092-8674(03)00079-5","volume":"112","author":"F Zalfa","year":"2003","unstructured":"Zalfa F, Giorgi M, Primerano B, Moro A, Di Penta A, Reis S, et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell. 2003;112:317\u201327.","journal-title":"Cell"},{"key":"3800_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nsmb.3462","volume":"24","author":"RR Edupuganti","year":"2017","unstructured":"Edupuganti RR, Geiger S, Lindeboom RGH, Shi H, Hsu PJ, Lu Z, et al. N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nat Struct Mol Biol. 2017;24:870\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"3800_CR16","doi-asserted-by":"publisher","first-page":"170166","DOI":"10.1098\/rsob.170166","volume":"7","author":"M Chang","year":"2017","unstructured":"Chang M, Lv H, Zhang W, Ma C, He X, Zhao S, et al. Region-specific RNA m(6)A methylation represents a new layer of control in the gene regulatory network in the mouse brain. Open Biol. 2017;7:170166.","journal-title":"Open Biol"},{"key":"3800_CR17","doi-asserted-by":"publisher","first-page":"17249","DOI":"10.1021\/jacs.7b09213","volume":"139","author":"AE Arguello","year":"2017","unstructured":"Arguello AE, DeLiberto AN, Kleiner RE. RNA chemical proteomics reveals the N(6)-methyladenosine (m(6)A)-regulated protein-RNA interactome. J Am Chem Soc. 2017;139:17249\u201352.","journal-title":"J Am Chem Soc"},{"key":"3800_CR18","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1261417","volume":"347","author":"S Geula","year":"2015","unstructured":"Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M, et al. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science. 2015;347:1002\u20136.","journal-title":"Science"},{"key":"3800_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u201395.","journal-title":"Nat Chem Biol"},{"key":"3800_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177\u201389.","journal-title":"Cell Res"},{"key":"3800_CR21","doi-asserted-by":"publisher","first-page":"33292","DOI":"10.1074\/jbc.M113.500397","volume":"288","author":"K Horiuchi","year":"2013","unstructured":"Horiuchi K, Kawamura T, Iwanari H, Ohashi R, Naito M, Kodama T, et al. Identification of Wilms\u2019 tumor 1-associating protein complex and its role in alternative splicing and the cell cycle. J Biol Chem. 2013;288:33292\u2013302.","journal-title":"J Biol Chem"},{"key":"3800_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537:369\u201373.","journal-title":"Nature"},{"key":"3800_CR23","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616\u201324.","journal-title":"Cell Res"},{"key":"3800_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885\u20137.","journal-title":"Nat Chem Biol"},{"key":"3800_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18\u201329.","journal-title":"Mol Cell"},{"key":"3800_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"3800_CR27","doi-asserted-by":"publisher","first-page":"e105977","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C. m(6) A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40:e105977.","journal-title":"EMBO J"},{"key":"3800_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.262766.115","volume":"29","author":"Y Yue","year":"2015","unstructured":"Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015;29:1343\u201355.","journal-title":"Genes Dev"},{"key":"3800_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuron.2017.12.036","volume":"97","author":"YL Weng","year":"2018","unstructured":"Weng YL, Wang X, An R, Cassin J, Vissers C, Liu Y, et al. Epitranscriptomic m(6)A regulation of axon regeneration in the adult mammalian nervous system. Neuron. 2018;97:313\u201325 e316.","journal-title":"Neuron"},{"key":"3800_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuron.2019.12.013","volume":"105","author":"H Xu","year":"2020","unstructured":"Xu H, Dzhashiashvili Y, Shah A, Kunjamma RB, Weng YL, Elbaz B, et al. m(6)A mRNA methylation is essential for oligodendrocyte maturation and CNS myelination. Neuron. 2020;105:293\u2013309 e295.","journal-title":"Neuron"},{"key":"3800_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2017.09.003","volume":"171","author":"KJ Yoon","year":"2017","unstructured":"Yoon KJ, Ringeling FR, Vissers C, Jacob F, Pokrass M, Jimenez-Cyrus D, et al. Temporal control of mammalian cortical neurogenesis by m(6)A methylation. Cell. 2017;171:877\u201389 e817.","journal-title":"Cell"},{"key":"3800_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41583-019-0244-z","volume":"21","author":"I Livneh","year":"2020","unstructured":"Livneh I, Moshitch-Moshkovitz S, Amariglio N, Rechavi G, Dominissini D. The m(6)A epitranscriptome: transcriptome plasticity in brain development and function. Nat Rev Neurosci. 2020;21:36\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"3800_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-018-0666-1","volume":"563","author":"H Shi","year":"2018","unstructured":"Shi H, Zhang X, Weng YL, Lu Z, Liu Y, Lu Z, et al. m(6)A facilitates hippocampus-dependent learning and memory through YTHDF1. Nature. 2018;563:249\u201353.","journal-title":"Nature"},{"key":"3800_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.neuron.2018.07.009","volume":"99","author":"M Engel","year":"2018","unstructured":"Engel M, Eggert C, Kaplick PM, Eder M, Roh S, Tietze L, et al. The role of m(6)A\/m-RNA methylation in stress response regulation. Neuron. 2018;99:389\u2013403 e389.","journal-title":"Neuron"},{"key":"3800_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature10989","volume":"485","author":"BJ O\u2019Roak","year":"2012","unstructured":"O\u2019Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485:246\u201350.","journal-title":"Nature"},{"key":"3800_CR36","doi-asserted-by":"publisher","first-page":"E5600","DOI":"10.1073\/pnas.1516376112","volume":"112","author":"I Iossifov","year":"2015","unstructured":"Iossifov I, Levy D, Allen J, Ye K, Ronemus M, Lee YH, et al. Low load for disruptive mutations in autism genes and their biased transmission. Proc Natl Acad Sci USA. 2015;112:E5600\u20135607.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3800_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature13772","volume":"515","author":"S De Rubeis","year":"2014","unstructured":"De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515:209\u201315.","journal-title":"Nature"},{"key":"3800_CR38","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41588-022-01148-2","volume":"54","author":"X Zhou","year":"2022","unstructured":"Zhou X, Feliciano P, Shu C, Wang T, Astrovskaya I, Hall JB, et al. Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes. Nat Genet. 2022;54:1305\u201319.","journal-title":"Nat Genet"},{"key":"3800_CR39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.celrep.2019.06.072","volume":"28","author":"BM Edens","year":"2019","unstructured":"Edens BM, Vissers C, Su J, Arumugam S, Xu Z, Shi H, et al. FMRP modulates neural differentiation through m(6)A-dependent mRNA nuclear export. Cell Rep. 2019;28:845\u201354 e845.","journal-title":"Cell Rep"},{"key":"3800_CR40","doi-asserted-by":"publisher","first-page":"19889","DOI":"10.1074\/jbc.AC119.010078","volume":"294","author":"PJ Hsu","year":"2019","unstructured":"Hsu PJ, Shi H, Zhu AC, Lu Z, Miller N, Edens BM, et al. The RNA-binding protein FMRP facilitates the nuclear export of N(6)-methyladenosine-containing mRNAs. J Biol Chem. 2019;294:19889\u201395.","journal-title":"J Biol Chem"},{"key":"3800_CR41","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1016\/j.molcel.2023.10.028","volume":"83","author":"Z Zou","year":"2023","unstructured":"Zou Z, Wei J, Chen Y, Kang Y, Shi H, Yang F, et al. FMRP phosphorylation modulates neuronal translation through YTHDF1. Mol Cell. 2023;83:4304\u201317 e4308.","journal-title":"Mol Cell"},{"key":"3800_CR42","doi-asserted-by":"publisher","first-page":"e104975","DOI":"10.15252\/embj.2020104975","volume":"40","author":"L Worpenberg","year":"2021","unstructured":"Worpenberg L, Paolantoni C, Longhi S, Mulorz MM, Lence T, Wessels HH, et al. Ythdf is a N6-methyladenosine reader that modulates Fmr1 target mRNA selection and restricts axonal growth in Drosophila. EMBO J. 2021;40:e104975.","journal-title":"EMBO J"},{"key":"3800_CR43","first-page":"3936","volume":"27","author":"F Zhang","year":"2018","unstructured":"Zhang F, Kang Y, Wang M, Li Y, Xu T, Yang W, et al. Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets. Hum Mol Genet. 2018;27:3936\u201350.","journal-title":"Hum Mol Genet"},{"key":"3800_CR44","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neuron.2019.02.041","volume":"101","author":"C Bagni","year":"2019","unstructured":"Bagni C, Zukin RS. A synaptic perspective of fragile X syndrome and autism spectrum disorders. Neuron. 2019;101:1070\u201388.","journal-title":"Neuron"},{"key":"3800_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","volume":"56","author":"G Dolen","year":"2007","unstructured":"Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, et al. Correction of fragile X syndrome in mice. Neuron. 2007;56:955\u201362.","journal-title":"Neuron"},{"key":"3800_CR46","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s12021-022-09581-8","volume":"20","author":"M Gerster","year":"2022","unstructured":"Gerster M, Waterstraat G, Litvak V, Lehnertz K, Schnitzler A, Florin E, et al. Separating Neural Oscillations from Aperiodic 1\/f Activity: Challenges and Recommendations. Neuroinformatics. 2022;20:991\u20131012.","journal-title":"Neuroinformatics"},{"key":"3800_CR47","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41593-020-00744-x","volume":"23","author":"T Donoghue","year":"2020","unstructured":"Donoghue T, Haller M, Peterson EJ, Varma P, Sebastian P, Gao R, et al. Parameterizing neural power spectra into periodic and aperiodic components. Nat Neurosci. 2020;23:1655\u201365.","journal-title":"Nat Neurosci"},{"key":"3800_CR48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s42003-022-03395-9","volume":"5","author":"EV Pedapati","year":"2022","unstructured":"Pedapati EV, Schmitt LM, Ethridge LE, Miyakoshi M, Sweeney JA, Liu R, et al. Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Commun Biol. 2022;5:442.","journal-title":"Commun Biol"},{"key":"3800_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpsychires.2021.03.057","volume":"138","author":"EG Smith","year":"2021","unstructured":"Smith EG, Pedapati EV, Liu R, Schmitt LM, Dominick KC, Shaffer RC, et al. Sex differences in resting EEG power in Fragile X Syndrome. J Psychiatr Res. 2021;138:89\u201395.","journal-title":"J Psychiatr Res"},{"key":"3800_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-022-00527-0","volume":"13","author":"LM Schmitt","year":"2022","unstructured":"Schmitt LM, Li J, Liu R, Horn PS, Sweeney JA, Erickson CA, et al. Altered frontal connectivity as a mechanism for executive function deficits in fragile X syndrome. Mol Autism. 2022;13:47.","journal-title":"Mol Autism"},{"key":"3800_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-017-0140-1","volume":"8","author":"LE Ethridge","year":"2017","unstructured":"Ethridge LE, White SP, Mosconi MW, Wang J, Pedapati EV, Erickson CA, et al. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome. Mol Autism. 2017;8:22.","journal-title":"Mol Autism"},{"key":"3800_CR52","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1016\/j.neuron.2023.09.014","volume":"111","author":"M Shen","year":"2023","unstructured":"Shen M, Sirois CL, Guo Y, Li M, Dong Q, Mendez-Albelo NM, et al. Species-specific FMRP regulation of RACK1 is critical for prenatal cortical development. Neuron. 2023;111:3988\u20134005 e3911.","journal-title":"Neuron"},{"key":"3800_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1101\/gr.251405.119","volume":"30","author":"M Li","year":"2020","unstructured":"Li M, Shin J, Risgaard RD, Parries MJ, Wang J, Chasman D, et al. Identification of FMR1-regulated molecular networks in human neurodevelopment. Genome Res. 2020;30:361\u201374.","journal-title":"Genome Res"},{"key":"3800_CR54","doi-asserted-by":"publisher","first-page":"10624","DOI":"10.1523\/JNEUROSCI.0402-10.2010","volume":"30","author":"C Gross","year":"2010","unstructured":"Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, et al. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci. 2010;30:10624\u201338.","journal-title":"J Neurosci"},{"key":"3800_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112764","volume":"42","author":"Y Cao","year":"2023","unstructured":"Cao Y, Ye Q, Ma M, She QB. Enhanced bypass of PD-L1 translation reduces the therapeutic response to mTOR kinase inhibitors. Cell Rep. 2023;42:112764.","journal-title":"Cell Rep"},{"key":"3800_CR56","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature11737","volume":"492","author":"M Ascano Jr.","year":"2012","unstructured":"Ascano M Jr., Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012;492:382\u20136.","journal-title":"Nature"},{"key":"3800_CR57","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1093\/nar\/gky267","volume":"46","author":"T Maurin","year":"2018","unstructured":"Maurin T, Lebrigand K, Castagnola S, Paquet A, Jarjat M, Popa A, et al. HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein. Nucleic Acids Res. 2018;46:6344\u201355.","journal-title":"Nucleic Acids Res"},{"key":"3800_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41593-018-0287-x","volume":"22","author":"SS Tran","year":"2019","unstructured":"Tran SS, Jun HI, Bahn JH, Azghadi A, Ramaswami G, Van Nostrand EL, et al. Widespread RNA editing dysregulation in brains from autistic individuals. Nat Neurosci. 2019;22:25\u201336.","journal-title":"Nat Neurosci"},{"key":"3800_CR59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"3800_CR60","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.stem.2024.04.019","volume":"31","author":"L Dao","year":"2024","unstructured":"Dao L, You Z, Lu L, Xu T, Sarkar AK, Zhu H, et al. Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids. Cell Stem Cell. 2024;31:818\u201333 e811.","journal-title":"Cell Stem Cell"},{"key":"3800_CR61","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrn4001","volume":"16","author":"JD Richter","year":"2015","unstructured":"Richter JD, Bassell GJ, Klann E. Dysregulation and restoration of translational homeostasis in fragile X syndrome. Nat Rev Neurosci. 2015;16:595\u2013605.","journal-title":"Nat Rev Neurosci"},{"key":"3800_CR62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1866-1955-6-16","volume":"6","author":"SM Sansone","year":"2014","unstructured":"Sansone SM, Schneider A, Bickel E, Berry-Kravis E, Prescott C, Hessl D. Improving IQ measurement in intellectual disabilities using true deviation from population norms. J Neurodev Disord. 2014;6:16.","journal-title":"J Neurodev Disord"},{"key":"3800_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09633-8","volume":"12","author":"AE Boggs","year":"2022","unstructured":"Boggs AE, Schmitt LM, McLane RD, Adayev T, LaFauci G, Horn PS, et al. Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots. Sci Rep. 2022;12:5617.","journal-title":"Sci Rep"},{"key":"3800_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29786-4","volume":"13","author":"D Straub","year":"2023","unstructured":"Straub D, Schmitt LM, Boggs AE, Horn PS, Dominick KC, Gross C, et al. A sensitive and reproducible qRT-PCR assay detects physiological relevant trace levels of FMR1 mRNA in individuals with Fragile X syndrome. Sci Rep. 2023;13:3808.","journal-title":"Sci Rep"},{"key":"3800_CR65","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/nprot.2012.116","volume":"7","author":"Y Shi","year":"2012","unstructured":"Shi Y, Kirwan P, Livesey FJ. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc. 2012;7:1836\u201346.","journal-title":"Nat Protoc"},{"key":"3800_CR66","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nbt.3777","volume":"35","author":"Y Qi","year":"2017","unstructured":"Qi Y, Zhang XJ, Renier N, Wu Z, Atkin T, Sun Z, et al. Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells. Nat Biotechnol. 2017;35:154\u201363.","journal-title":"Nat Biotechnol"},{"key":"3800_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100954","volume":"2","author":"BE Guler","year":"2021","unstructured":"Guler BE, Krzysko J, Wolfrum U. Isolation and culturing of primary mouse astrocytes for the analysis of focal adhesion dynamics. STAR Protoc. 2021;2:100954.","journal-title":"STAR Protoc"},{"key":"3800_CR68","doi-asserted-by":"publisher","first-page":"14223","DOI":"10.1523\/JNEUROSCI.3157-11.2011","volume":"31","author":"SA Hays","year":"2011","unstructured":"Hays SA, Huber KM, Gibson JR. Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry. J Neurosci. 2011;31:14223\u201334.","journal-title":"J Neurosci"},{"key":"3800_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","volume":"134","author":"A Delorme","year":"2004","unstructured":"Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004;134:9\u201321.","journal-title":"J Neurosci Methods"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03800-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03800-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03800-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:02:52Z","timestamp":1785528172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03800-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":69,"alternative-id":["3800"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03800-3","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The human subject research and experimental protocols involving patient-derived materials and clinical data were reviewed and approved by the Institutional Review Board (IRB) of Cincinnati Children\u2019s Hospital Medical Center (CCHMC) under protocol ID 2013-7327. All study procedures were conducted in strict accordance with relevant guidelines and regulations, including the Declaration of Helsinki. Written informed consent was obtained from all participants or their legal guardians prior to their participation in the study, and verbal assent was provided by participants where appropriate. Animal protocols were reviewed and approved by the Cincinnati Children\u2019s Hospital Medical Center Institutional Animal Care and Use Committee (IACUC).\n                      Fmr1\n                      -KO and wild-type brain tissues were kindly provided by the laboratory of Dr. Christina Gross post-euthanasia. Consequently, no live vertebrate experiments were conducted by the authors of this manuscript.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The provisional patent application was filed on January 15, 2026 as US 63\/960,854 application serial number.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}